Stockscreener 앱 받기
5.06
5.53%
0.265
시간 외 거래:
5.43
0.37
+7.31%
Cryoport Inc 주식(CYRX)의 최신 뉴스
CryoPort Inc (CYRX) Q4 2024 Earnings: EPS Misses, Revenue Surpas - GuruFocus.com
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Cryoport Inc earnings missed by $0.13, revenue topped estimates - Investing.com
Cryoport stock hits 52-week low at $5.3 amid market challenges By Investing.com - Investing.com South Africa
CryoPort Inc (CYRX) Q4 2024: Everything You Need To Know Ahead O - GuruFocus.com
CryoPort Inc (CYRX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
CRYOPORT Earnings Preview: Recent $CYRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Cryoport (CYRX) Projected to Post Earnings on Tuesday - Defense World
Cryoport Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Did Cryoport, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- CYRX - ACCESS Newswire
How to Take Advantage of moves in (CYRX) - Stock Traders Daily
Market Cool On Cryoport, Inc.'s (NASDAQ:CYRX) Revenues Pushing Shares 25% Lower - Simply Wall St
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Eastern Progress Online
Cryoport, Inc. (NASDAQ:CYRX) Receives $12.29 Consensus Target Price from Brokerages - Defense World
CYRXCryoport Inc Latest Stock News & Market Updates - StockTitan
Cryoport Q4 Earnings Date Revealed: Key Financial Insights Coming March 4 - StockTitan
Investor Network: Cryoport, Inc. to Host Earnings Call - ACCESS Newswire
Cryoport, Inc. (NASDAQ:CYRX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
(CYRX) Investment Analysis - Stock Traders Daily
The Schall Law Firm has initiated a probe into claims against Cryoport, Inc. (CYRX) and encourages its investors to make contact - ACCESS Newswire
Cryoport Falls To US$6.99, But Insiders Sold At Lower Price - Simply Wall St
When (CYRX) Moves Investors should Listen - Stock Traders Daily
Short Interest in Cryoport, Inc. (NASDAQ:CYRX) Declines By 5.5% - Defense World
SG Americas Securities LLC Purchases 45,430 Shares of Cryoport, Inc. (NASDAQ:CYRX) - MarketBeat
Cryoport (NASDAQ:CYRX) investors are sitting on a loss of 80% if they invested three years ago - Yahoo Finance
SG Americas Securities LLC Buys 45,430 Shares of Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019 - BioSpace
Cryoport, Inc. to Host Earnings Call - ACCESS Newswire
Cryoport, Inc. (NASDAQ:CYRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Cryoport, Inc. (NASDAQ:CYRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies - PR Newswire
JPMorgan Chase & Co. Buys 285,726 Shares of Cryoport, Inc. (NASDAQ:CYRX) - Defense World
JPMorgan Chase & Co. Increases Stake in Cryoport, Inc. (NASDAQ:CYRX) - MarketBeat
Cryoport, Inc. (NASDAQ:CYRX) Sees Large Decrease in Short Interest - MarketBeat
Assenagon Asset Management S.A. Reduces Holdings in Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Assenagon Asset Management S.A. Sells 143,378 Shares of Cryoport, Inc. (NASDAQ:CYRX) - MarketBeat
Needham & Company LLC Reiterates “Buy” Rating for Cryoport (NASDAQ:CYRX) - Defense World
Cryoport (NASDAQ:CYRX) Earns Buy Rating from Needham & Company LLC - MarketBeat
Barclays PLC Has $660,000 Stock Holdings in Cryoport, Inc. (NASDAQ:CYRX) - Defense World
Barclays PLC Boosts Stake in Cryoport, Inc. (NASDAQ:CYRX) - MarketBeat
Moffitt Cancer Center Partners with Cryoport - Contract Pharma
Trend Tracker for (CYRX) - Stock Traders Daily
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration - WV News
Cryoport had a rough 2024, here's what CEO Jerrell Shelton said is in store - The Business Journals
Cryoport (NASDAQ:CYRX) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Cryoport (NASDAQ:CYRX) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Cryoport facilities land FDA approval - The Business Journals
Strong week for Cryoport (NASDAQ:CYRX) shareholders doesn't alleviate pain of three-year loss - Simply Wall St
Cryoport’s MVE Biological Solutions Registers Mfg. Facilities with FDA - Contract Pharma
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA") - IT News Online
6.03%
자본화:
|
볼륨(24시간):